Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer.

Koinis, Filippos; Corn, Paul; Parikh, Nila; Song, Jian; Vardaki, Ioulia; Mourkioti, Ioanna; Lin, Sue-Hwa; Logothetis, Christopher; Panaretakis, Theocharis; Gallick, Gary

Koinis, Filippos; Corn, Paul; Parikh, Nila; Song, Jian; Vardaki, Ioulia; Mourkioti, Ioanna; Lin, Sue-Hwa; Logothetis, Christopher; Panaretakis, Theocharis; Gallick, Gary.

Afiliação

Koinis F; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Corn P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Parikh N; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Song J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Vardaki I; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mourkioti I; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Lin SH; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Logothetis C; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Panaretakis T; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Gallick G; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.